Lonidamine

DRUG2 trials

Sponsors

Threshold Pharmaceuticals

Conditions

Benign Prostatic HyperplasiaEnlarged Prostate

Phase 2

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

TerminatedNCT00237536

Threshold PharmaceuticalsBenign Prostatic Hyperplasia

Start: 2005-06-30End: 2006-08-31Target: 240Updated: 2009-04-29

Phase 3

Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

TerminatedNCT00435448

Threshold PharmaceuticalsBenign Prostatic Hyperplasia, Enlarged Prostate

Start: 2005-06-30End: 2006-12-31Target: 480Updated: 2009-04-29